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STUDY QUESTION: Does septum resection improve reproductive outcomes in women with a septate uterus?
SUMMARY ANSWER: In women with a septate uterus, septum resection does not increase live birth rate nor does it decrease the rates
of pregnancy loss or preterm birth, compared with expectant management.
WHAT IS KNOWN ALREADY: The septate uterus is the most common uterine anomaly with an estimated prevalence of 0.2–2.3% in
women of reproductive age, depending on the classification system. The definition of the septate uterus has been a long-lasting and ongoing
subject of debate, and currently two classification systems are used worldwide. Women with a septate uterus may be at increased risk of
subfertility, pregnancy loss, preterm birth and foetal malpresentation. Based on low quality evidence, current guidelines recommend removal
of the intrauterine septum or, more cautiously, state that the procedure should be evaluated in future studies.
STUDY DESIGN, SIZE, DURATION: We performed an international multicentre cohort study in which we identified women mainly
retrospectively by searching in electronic patient files, medical records and databases within the time frame of January 2000 until August 2018.
Searching of the databases, files and records took place between January 2016 and July 2018. By doing so, we collected data on 257 women
with a septate uterus in 21 centres in the Netherlands, USA and UK.
PARTICIPANTS/MATERIALS, SETTING, METHODS: We included women with a septate uterus, defined by the treating physician,
according to the classification system at that time. The women were ascertained among those with a history of subfertility, pregnancy loss,
preterm birth or foetal malpresentation or during a routine diagnostic procedure. Allocation to septum resection or expectant management
was dependent on the reproductive history and severity of the disease. We excluded women who did not have a wish to conceive at time
of diagnosis. The primary outcome was live birth. Secondary outcomes included pregnancy loss, preterm birth and foetal malpresentation. All
conceptions during follow-up were registered but for the comparative analyses, only the first live birth or ongoing pregnancy was included. To
evaluate differences in live birth and ongoing pregnancy, we used Cox proportional regression to calculate hazard rates (HRs) and 95% CI. To
evaluate differences in pregnancy loss, preterm birth and foetal malpresentation, we used logistic regression to calculate odds ratios (OR) with
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MAIN RESULTS AND THE ROLE OF CHANCE: In total, 257 women were included in the cohort. Of these, 151 women underwent
a septum resection and 106 women had expectant management. The median follow-up time was 46 months. During this time, live birth
occurred in 80 women following a septum resection (53.0%) compared to 76 women following expectant management (71.7%) (HR 0.71
95% CI 0.49–1.02) and ongoing pregnancy occurred in 89 women who underwent septum resection (58.9%), compared to 80 women who
had expectant management (75.5%) (HR 0.74 (95% CI 0.52–1.06)). Pregnancy loss occurred in 51 women who underwent septum resection
(46.8%) versus 31 women who had expectant management (34.4%) (OR 1.58 (0.81–3.09)), while preterm birth occurred in 26 women who
underwent septum resection (29.2%) versus 13 women who had expectant management (16.7%) (OR 1.26 (95% CI 0.52–3.04)) and foetal
malpresentation occurred in 17 women who underwent septum resection (19.1%) versus 27 women who had expectant management (34.6%)
(OR 0.56 (95% CI 0.24–1.33)).
LIMITATIONS, REASONS FOR CAUTION: Our retrospective study has a less robust design compared with a randomized controlled
trial. Over the years, the ideas about the definition of the septate uterus has changed, but since the 257 women with a septate uterus included
in this study had been diagnosed by their treating physician according to the leading classification system at that time, the data of this study
reflect the daily practice of recent decades. Despite correcting for the most relevant patient characteristics, our estimates might not be free of
residual confounding.
WIDER IMPLICATIONS OF THE FINDINGS: Our results suggest that septum resection, a procedure that is widely offered and associated
with financial costs for society, healthcare systems or individuals, does not lead to improved reproductive outcomes compared to expectant
management for women with a septate uterus. The results of this study need to be confirmed in randomized clinical trials.
STUDY FUNDING/COMPETING INTEREST(S): A travel for JFWR to Chicago was supported by the Jo Kolk Studyfund. Otherwise, no
specific funding was received for this study. The Department of Obstetrics and Gynaecology, University Medical Centre, Groningen, received
an unrestricted educational grant from Ferring Pharmaceutical Company unrelated to the present study. BWM reports grants from NHMRC,
personal fees from ObsEva, personal fees from Merck, personal fees from Guerbet, other payment from Guerbet and grants from Merck,
outside the submitted work. The other authors declare no conficts of interest.
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Introduction
The septate uterus is the most common uterine anomaly with an
estimated prevalence of 0.2–2.3% in women of reproductive age,
depending on the diagnostic method and classification system (Chan
et al., 2011a; Ludwin and Ludwin, 2015). Women with a septate uterus
may be at increased risk of subfertility, pregnancy loss, preterm delivery
and foetal malpresentation (Chan et al., 2011b). The classification of
uterine anomalies, and the definition of the septate uterus in particular,
is a long-lasting and ongoing subject of debate, and currently two main
classification systems are used worldwide: the ASRM (AFS) classifica-
tion of 1988 that was modified in 2016 and the ESHRE-ESGE classifica-
tion of 2013 (Grimbizis et al., 2013; ASRM, 2016; Ludwin et al., 2018).
Compared to the ASRM classification, the ESHRE-ESGE classification
seems to lead to an over diagnosis of the septate uterus, using the
uterine wall thickness as part of their definition (Ludwin and Ludwin,
2015). Since both classification systems have not found a worldwide
acceptance so far, in 2018 a study assessed the level of agreement
between experts in distinguishing between a septate and normal/arcu-
ate and used this agreement as a reference standard called Congenital
Uterine Malformation by Experts (CUME) (Ludwin et al., 2018).
The biological basis for the impaired reproductive outcomes in
women with a septate uterus has not yet been clarified. According to
a recent systematic literature review, the vascularization, myometrium
and endometrium of the intrauterine septum are similar to the normal
uterine wall. The only pathophysiological differences seem to be a
lower expression of HOXA10 genes and VEGF receptor genes and































































lining of the intrauterine septum. The reviewers concluded that these
differences in histological composition of the endometrium, or the
presence of the septum itself or other yet unknown factors, possibly
account for the impaired reproductive outcomes (Rikken et al., 2019).
To improve reproductive outcomes, hysteroscopic septum resection
has long been the standard of care in women with a septate uterus
(Valle and Ekpo, 2013). Current evidence for this procedure is based on
observational studies in which all women underwent septum resection
in before/after design studies and in non-randomized comparative
studies in which women could choose between septum resection and
expectant management. Based on this low quality evidence (Grade
C) current guidelines have different recommendations: the ASRM
guideline for septate uterus recommends to remove the intrauterine
septum (ASRM, 2016); the NICE guideline of recurrent miscarriage
states that ‘current evidence on efficacy is adequate to support the
use of this procedure provided that normal arrangements are in place
for clinical governance, consent and audit’; and the ESHRE guideline
for recurrent pregnancy loss and the RCOG guideline recurrent mis-
carriage recommend not to perform the surgery and state that the
procedure should be evaluated in future studies (RCOG, 2011; NICE,
2015; ESHRE, 2017).
In view of the persisting uncertainty around the effectiveness of
septum resection, we performed a large international multicentre
cohort study in women with a septate uterus and a wish to conceive,
who electively chose for septum resection or expectant management.
In this study we corrected for all possible confounders. Our aim
was to determine whether hysteroscopic septum resection improves

















This study was an international multicentre cohort study including
women with a septate uterus with a wish to conceive. We constructed
the manuscript according to the STROBE guideline.
Recruitment and follow-up
We included women mainly retrospectively in 18 centres in the
Netherlands, 2 centres in the USA and 1 centre in the UK. First, in
all centres in the Netherlands, USA and UK, we identified women
retrospectively by searching via keywords ‘septate uterus’, ‘uterus
anomaly’ and ‘septum resection’ in electronic patient files and medical
records, within the time frame of January 2000 until August 2018. At
the University of Illinois, Chicago, we also identified women searching
via the keywords ‘septate uterus’ and ‘uterus anomaly’ in a recurrent
pregnancy loss database. The database search took place between
January 2016 and May 2018 in the Netherlands, between April and
June 2017 in the USA and between June and July 2018 in the UK.
In addition, we included women prospectively in the Dutch centres.
After having obtained ethical approval for this cohort study in March
2015, women who declined to participate in the TRUST study (a
randomized controlled trial in which women with a septate uterus
are allocated to septum resection or expectant management, NTR
1676) were asked to participate in the current study until August 2018.
We extracted data on baseline characteristics, interventions and on all
pregnancies that occurred during follow-up via their medical records.
In the Netherlands, eligible women were, if necessary, contacted by
their physician to complete follow-up.
Study population
The study population consisted of women with a septate uterus
and a wish to conceive. Allocation to septum resection or expec-
tant management was arbitrary and dependent on the reproductive
history and severity of the disease. The septate uterus was ascer-
tained in women with a history of subfertility, pregnancy loss or
preterm birth but could also have been identified during a gynaeco-
logical examination, an ultrasound in pregnancy or during a caesarean
section.
Definitions
Subfertility was defined as the inability to conceive for a minimal
period of 1 year of trying to conceive (Zegers-Hochschild et al.,
2017); a conception was defined as a positive pregnancy test; ongoing
pregnancy was defined as a viable intrauterine pregnancy of at least
12 weeks duration confirmed on an ultrasound scan (Braakhekke
et al., 2014); a pregnancy loss was defined as the spontaneous demise
of a pregnancy before 24 weeks of gestation; recurrent pregnancy
loss was defined as two or more, not necessarily consecutive, preg-
nancy losses before 24 weeks of gestational age (ESHRE, 2017);
preterm birth was defined as birth before a gestational age of 37
complete weeks (Blencowe et al., 2013); and foetal malpresentation
was defined as a non-cephalic presentation of the foetus at term. A





























































































































classification system at that time (AFS, 1988; Grimbizis et al., 2013;
ASRM, 2016).
The presence of a septate uterus was ascertained by hysterosalp-
ingography (HSG), 3D ultrasound (3D-US), MRI, saline or gel infu-
sion sonohysterography or hysteroscopy combined with laparoscopy
(Faivre et al., 2012; Ludwin et al., 2014a; Siam and Soliman, 2014;
Graupera et al., 2015).
The moment of diagnosis of the septate uterus was time zero;
all pregnancies before diagnosis were considered obstetrical history,
and all pregnancies after diagnosis were follow-up. When the
septate uterus was found in pregnancy, we decided to take that
pregnancy as obstetrical history and all subsequent pregnancies as
follow-up.
Ethical approval
The Medical Ethical Committee of the Academic Medical Centre,
Amsterdam, the Netherlands, stated that the Medical Research Involv-
ing Human Subjects Act (WMO) did not apply to this study and
that an official approval of this study by our committee was not
required (W17_051). In the Netherlands, all women gave informed
consent for this study. In the USA, we used a recurrent pregnancy loss
database created by one of the co-authors (MDS) for which women
consented previously and previous ethical approval was obtained from
the Institutional Review Board at the University of Chicago and the
University of Illinois at Chicago, USA (#2017-0324). In the UK, we
obtained ethical approval for use of a research database of women with
a septate uterus (IRAS project ID 268876) without requiring informed
consent.
Outcome measures
The primary outcome measure was live birth, defined as the birth of a
living child beyond 24 weeks of gestational age. Secondary outcomes
were ongoing pregnancy, early pregnancy loss, preterm birth and foetal
malpresentation.
Statistical analyses
A descriptive analysis was performed to compare baseline character-
istics between women in the septum resection and expectant manage-
ment arms. All conceptions during follow-up were registered but for
the comparative analyses, only the first live birth or ongoing pregnancy
was used.
To evaluate differences in live birth and ongoing pregnancy between
the women in the two arms while accounting for follow-up time,
we used Cox proportional regression to calculate hazard rates (HRs)
and 95% CI. To evaluate differences in pregnancy loss, preterm birth
and foetal malpresentation, we used logistic regression to calculate
odds ratios (OR) with corresponding 95% CI. We adjusted for age,
BMI, smoking, ethnicity, country, classification, diagnostic procedure,
subfertility, pregnancy loss, preterm birth and previous live birth.
To visualize differences in predicted proportion of live birth over
time between women who underwent septum resection and women
who had expectant management, we plotted adjusted survival curves.
Women in whom the septate uterus was diagnosed during their
pregnancy were included in all analyses, except when we evaluated
differences in live birth within 1 year after diagnosis of the septate
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Figure 1 Flowchart of recruitment and inclusion/exclusion criteria.
uterus, as the pregnancy at time zero affects the time to a subse-
quent analysis. To explore differences in women with a history of
pregnancy loss or a history of subfertility separately, we performed
subanalyses in these women. We imputed any missing values for
potential confounders for which we adjusted in the analyses using the
MICE method for multiple imputation with standard errors based on




After obtaining approval in 2015, we included 20 women prospectively
in the Netherlands. In retrospect, we identified 123 women in the
Netherlands, 77 in the UK and 71 in the USA. Of the 291 women
we examined for eligibility, we excluded 34 women because they did
not have a wish to conceive at time of diagnosis. In total, 257 women
were confirmed eligible and were included in the study for analysis
(Fig. 1).
Baseline characteristics
Women had a septum diagnosed between February 1981 and March
2018. Of the 257 included women, 151 women underwent septum
resection and 106 women had expectant management. Baseline char-
acteristics are summarized in Table I. In women who underwent sep-
tum resection, a lower percentage was of Caucasian origin compared
to women who had expectant management. Between countries, there
was a difference in distribution of women who underwent septum
resection and who had expectant management. In women who under-
went septum resection, ascertainment of the septate uterus was signif-
icantly different compared to women who had expectant management











































































history of subfertility (n = 54 vs n = 21). In women in whom the septate
uterus was ascertained in pregnancy, fewer women underwent septum
resection compared to women who had expectant management (n = 0
vs n = 19). In 10 of the 19 women who had expectant management
and in whom the septate uterus was ascertained in pregnancy, the
septate uterus was diagnosed during caesarean section because of
malpresentation. Women who underwent septum resection had a
significantly lower percentage of previous live birth compared with
women who had expectant management (n = 25 (16.6%) vs n = 39
(36.8%), P < 0.001). The majority of included women were diagnosed
with a partial septate uterus: 119 women who underwent septum
resection (81.5%) and 87 women who had expectant management
(86.1%). The septate uterus was mainly diagnosed by hysteroscopy
combined with laparoscopy, as was the case in 76 women who under-
went septum resection (52.8%) and 33 women who had expectant
management (31.7%).
Septum resection
In 151 women who underwent septum resection, 73 women (48.3%)
had the procedure performed with a Versa point device, 32 women
(21.2%) with scissors, 12 women (7.9%) with electro-surgery and in
34 women the technique of septum resection was unknown. Control
of the depth of the resection was performed via laparoscopy (n = 59
women) or via ultrasound (n = 4 women) or such control was not
performed (n = 60). The intrauterine septum was completely removed
in 128 (84.8%) of included women. Complications occurred in seven
women (4.6%); in three women there was a perforation, in one woman
the maximal allowed amount of intravasation was reached and in three
women there was more blood loss than was deemed acceptable. In
all of these seven women, the procedure was stopped prematurely
and a second procedure was done without any complications. Control
hysteroscopy was performed in 72 women (47.7%), and in 16 of these
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Table I Baseline characteristics.
Septum resection (n = 151) Expectant management (n = 106) P-value
.....................................................................................................................................................................................
Age (mean, SD) 31.7 (4.18) 30.8 (5.09) 0.10
.....................................................................................................................................................................................
BMI (mean, SD) 25.4 (5.11) 24.8 (5.02) 0.34
.....................................................................................................................................................................................
Ethnicity 0.001
Caucasian 119 (83.8%) 88 (89.8%)




The Netherlands 65 (43.0%) 66 (62.3%)
Birmingham, UK 48 (31.8%) 7 (6.6%)
Chicago, USA 38 (25.2%) 33 (31.1%)
.....................................................................................................................................................................................
Smoking 0.45
Yes 12 (8%) 5 (4.8%)




Subfertility 54 (36.0%) 21 (20.4%)
Pregnancy loss 72 (48.0%) 43 (41.8%)
Preterm birth 19 (12.7%) 11 (10.7%)
In pregnancy 0 (0%) 19 (18.4%)
Other 5 (3.3%) 9 (8.7%)
Unknown 1 3
.....................................................................................................................................................................................
Previous live birth <0.001
Yes 25 (16.6%) 39 (36.8%)
No 126 (83.4%) 67 (63.2%)
.....................................................................................................................................................................................
Classification 0.39
Partial septate uterus 119 (81.5%) 87 (86.1%)




SIS/GIS 8 (5.6%) 9 (8.7%)
3D US 9 (6.3%) 20 (19.2%)
MRI 22 (15.3%) 8 (7.7%)
Hyst+lap 76 (52.8%) 33 (31.7%)
HSG 29 (20.1%) 21 (20.2%)
Caesarean Section 0 (0%) 13 (12.5%)
Unknown 7 2
n (%)
SD = standard deviation
Hyst + lap = hysteroscopy + laparoscopy
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Figure 2 Flow diagram of reproductive outcomes.
Long-term reproductive outcomes
The flow of women during the follow-up of the study is shown in
Fig. 2. The median duration of follow-up was 46 months: 40 months for
women who underwent septum resection and 53 months for women
who had expectant management.
The reproductive outcomes are shown in Table II. Overall, 80 of
151 women who underwent septum resection (53.0%) had at least




















management (71.7%) (HR 0.71 (95% CI 0.49–1.02)) (Table II). There
were no significant differences in cumulative live birth between
women who underwent septum resection and women who had
expectant management, as can be seen in the survival plot adjusted
for confounders (Fig. 3). When we analysed the chance of a live birth
within 1 year after diagnosis of the septate uterus, 32 women who
underwent septum resection had a live birth (21.2%) compared to
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Figure 3 Adjusted cumulative live birth. Adjusted for age, BMI, smoking, ethnicity, country, classification, diagnostic procedure, subfertility,
pregnancy loss, preterm birth and previous live birth.
Women who underwent septum resection had a non-significantly
decreased chance of ongoing pregnancy (HR 0.74 (95% CI 0.52–1.06))
and foetal malpresentation (OR 0.56 (95% CI 0.24–1.33)), and a non-
significantly increased chance of pregnancy loss (OR 1.58 (95% CI
0.81–3.09) and preterm birth (OR 1.26 (95% CI 0.52–3.04)) (Table II).
All malpresentations were breech.
Subgroup analyses
Women with an obstetrical history of one or more pregnancy losses
and who underwent septum resection had an increased risk of another
pregnancy loss, compared to women who had expectant management
(OR 2.65 (95% CI 1.05–6.67)) (Table III). In women with a history
of subfertility, there were no differences in reproductive outcomes
between the two groups (Table IV). In a subanalysis on women with
a complete septate uterus, women who underwent septum resec-
tion had a decreased chance on an ongoing pregnancy, compared
to women who had expectant management (HR 0.26 (0.07–0.91))
(Supplementary Table SI).
Discussion
In this cohort study, more than half of the women with a septate
uterus had a live birth. Septum resection did not lead to improved
reproductive outcomes compared to expectant management in these
women; septum resection did not increase the chance of live birth,
nor did it decrease the chance of pregnancy loss or preterm birth. In
contrast, septum resection may have decreased the chance of foetal
malpresentation.
Strengths and limitations
Our study has a number of strengths. First, for this multicentre








































































centres worldwide, with a specifically large proportion of women
who had expectant management. The relatively large sample size
in combination with a long follow-up resulted in a unique study
population, which embodies daily practice as well as possible. Second,
since a retrospective study is by design at risk of selection bias, we
adjusted for possible differences in prognostic factors between women
who underwent a septum resection and women who had expectant
management. Third, the observational study design enabled us to
thoroughly describe baseline characteristics as well as reproductive
outcomes.
Our study has also limitations. First, an adequately powered, ran-
domized controlled trial obviously offers the best way to evaluate the
effectiveness of septum resection compared to expectant manage-
ment. Our observational study following a cohort of women with a
septate uterus who either underwent septum resection or had expec-
tant management is a less robust design. In this cohort particularly,
women who chose expectant management could be considered as
‘better prognosis patients’, since 19 women who chose expectant
management were pregnant at time of diagnosis of the septate uterus,
compared to none of the women who underwent septum resection.
We tried to correct all analyses for the most important patient charac-
teristics, but nevertheless our results could still be influenced by residual
confounding.
Second, we collected the data of women with a septate uterus
between 1981 and 2018, and during that period the ideas and concepts
on the classification of uterine anomalies and the best diagnostic
tool to differentiate between septate, arcuate and bicornuate uterus
changed (Ludwin and Ludwin, 2015). In fact, the discussion about
the most accurate definition of the septate uterus is still ongoing
(Grimbizis et al., 2013; ASRM, 2016; Ludwin et al., 2018; Ludwin
et al., 2019). In addition, saline or gel infusion sonohysterography
and 3D-ultrasound is currently considered as the most accurate test
for diagnosing the septate uterus, but this was not available in the












trecht user on 10 M
ay 2021












Yes 109 (72.2%) 90 (84.9%)
No 42 (27.8%) 16 (15.1%)........................................................................................
Live birth HR 0.71
(0.49–1.02)
Yes 80 (53.0%) 76 (71.7%)





Yes 89 (58.9%) 80 (75.5%)
No 62 (41.1%) 26 (24.5%)........................................................................................
........................................................................................
Pregnancy loss (% of conception) OR 1.58
(0.81–3.09)
Yes 51 (46.8%) 31 (34.4%)
No 58 (53.2%) 59 (65.6%)........................................................................................
Preterm birth (% of ongoing pregnancy) OR 1.26
(0.52–3.04)
Yes 26 (29.2%) 13 (16.7%)
No 63 (70.8%) 65 (83.3%)
Unknown 2........................................................................................
Malpresentation (% of ongoing pregnancy) OR 0.56
(0.24–1.33)
Yes 17 (19.1%) 27 (34.6%)
No 72 (80.9%) 51 (65.4%)
Unknown 2
OR = odds rate, HR = hazard rate, CI = confidence interval
Only the first live birth or first ongoing pregnancy per woman was included. All
malpresentations were breech.
All outcomes were adjusted for age, BMI, smoking, ethnicity, country, classification,
diagnostic procedure, subfertility, pregnancy loss, preterm birth and previous live birth.
time period in which some of our patients were diagnosed (Ludwin
et al., 2014a). In this pragmatic study, we included 257 women with
a septate uterus who were diagnosed by their treating physician in 21
centres worldwide, according to the leading classification system at that
time. For all of these women, there was a decision to be made: to
resect the septum or not. So, we here present the data of a retro-
spective cohort study that reflects the daily practice of the past four
decades.
Third, the retrospective design inevitably implies that we have limited
data on quality of surgical care and assessment of the anatomic results
(Ludwin et al., 2014b). Although we corrected our reproductive out-
comes for the differentiation between a partial and complete septate
uterus, we could not correct for size of the septum, since we had
detailed information on the thickness of the septum in just 17 women
(6.6%) and information on the length of the septum in just 27 women





























































































































Table III Reproductive outcomes of all women with a












Yes 72 (78.3%) 40 (80%)
No 20 (21.7%) 10 (20%)
.......................................................................................
Live birth HR 0.61
(0.36–1.02)
Yes 47 (51.1%) 29 (58%)






Yes 54 (58.7%) 32 (64%)
No 38 (41.3%) 18 (36%)
.......................................................................................
.......................................................................................
Pregnancy loss (% of conception) OR 2.65
(1.05–6.67)
Yes 42 (58.3%) 16 (40%)
No 30 (41.7%) 24 (60%)
.......................................................................................
Preterm birth (% of ongoing pregnancy) OR 1.23
(0.35–4.30)
Yes 19 (35.1%) 7 (23.3%)
No 35 (64.8%) 23 (76.7%)
Unknown 2
.......................................................................................
Malpresentation (% of ongoing pregnancy) OR 0.99
(0.23–4.29)
Yes 9 (14.8%) 6 (20%)
No 46 (85.2%) 24 (80%)
Unknown 2
OR = odds rate, CI = confidence interval
Only the first live birth or first ongoing pregnancy per woman was included.
All outcomes were adjusted for age, BMI, smoking, ethnicity, country, classification,
diagnostic procedure, subfertility, preterm birth and previous live birth.
treatment of the patient or physician and possibly led to confounding
by indication.
Literature
Our findings are in contrast with the current literature on septum resec-
tion. Observational studies with a before/after design have reported
spectacular outcomes after septum resection, as summarized in a
review in which live birth rates and pregnancy loss rates of 16 studies
(658 women) were pooled: the number of term deliveries before
and after septum resection were 34 (3%) versus 395 (80%) and
the number of pregnancy losses were 933 (88%) versus 67 (14%)













trecht user on 10 M
ay 2021













Yes 38 (63.3%) 20 (71.4%)
No 22 (36.7%) 8 (28.6%)........................................................................................
Live birth HR 0.90
(0.63–1.28)
Yes 32 (53.3%) 17 (60.7%)





Yes 35 (58.3%) 17 (60.7%)
No 25 (41.7%) 11 (39.3%)........................................................................................
........................................................................................
Pregnancy loss (% of conception) OR 1.07
(0.28–4.13)
Yes 15 (39.5%) 9 (45%)
No 23 (60.5%) 11 (55%)........................................................................................
Preterm birth (% of ongoing pregnancy) OR 1.75
(0.17–17.54)
Yes 9 (25.7%) 4 (23.5%)
No 26 (74.3%) 13 (76.5%)........................................................................................
Malpresentation (% of ongoing pregnancy) OR 0.39
(0.08–2.03)
Yes 9 (25.7%) 8 (47.1%)
No 26 (74.3%) 9 (52.9%)
OR = odds rate, CI = confidence interval
Only the first live birth or first ongoing pregnancy per woman was included.
All outcomes were adjusted for age, BMI, smoking, ethnicity, country, classification,
diagnostic procedure, pregnancy loss, preterm birth and previous live birth.
with caution for two reasons: first, the ‘before/after’ design always
favours the tested intervention. Second, these studies did not correct
for confounders. The results of non-randomized comparative stud-
ies in which all women underwent septum resection or had expec-
tant management showed either positive effects of septum resec-
tion or no differences in reproductive outcome (Chan et al., 2011b).
None of these studies corrected for confounding variables. Four
studies had a very small sample size with, respectively, 11 women
(Maneschi et al., 1991), 43 women (Valli et al., 2004), 35 women (Lin
et al., 2009) and 60 women (Pang et al., 2011). Two studies were
at high risk of selection bias because of the unequal distribution of
women: 102 women who underwent septum resection versus 25
women who had expectant management (Tonguc et al., 2011) and
109 women who underwent septum resection versus 15 women who
had expectant management (Sugiura-Ogasawara et al., 2015). We feel






























































































































In our study we found a relatively high overall live birth rate: 53.0%
in women who underwent septum resection and 71.7% in women
who chose expectant management, which can be clarified by our long
follow-up period and is in line with the live birth reported in literature
(Pang et al., 2011; Sugiura-Ogasawara et al., 2015). This explanation is
supported by the observation that the chance of live birth within 1 year
was 21.2% in women who underwent septum resection versus 37.1%
in women who chose expectant management.
In women who underwent septum resection, 26 women had a
preterm birth (29.2%), compared to 13 women who chose expectant
management (16.7%) (OR 1.26 (95% CI 0.52–3.04)). In women with
a complete septate uterus, women who underwent septum resection
had a decreased chance on an ongoing pregnancy compared to women
who had expectant management (HR 0.26 (CI 0.07–0.91)). These are
unexpected findings that need to be confirmed or refuted in larger
studies.
For decades, the recommendation worldwide has been to perform
septum resection based on low-graded evidence. The procedure is
widely offered but is associated with financial costs for the society,
healthcare systems or individuals. We feel that we here have shown
that septum resection is not without risks, has no clear benefits and
should not be performed unless the evidence that it improves repro-
ductive outcomes in women is convincingly solid.
Conclusion
In our study, septum resection does not lead to improved pregnancy
outcomes compared to expectant management in women with a
septate uterus. These findings underline that a randomized controlled
trial is urgently needed. The follow-up of such an RCT is complete
by the end of 2019 (Netherlands Trial Register (NTR) 1676). Awaiting
those results, septum resection should not be performed unless as part
of a clinical trial.
Supplementary data
Supplementary data are available at Human Reproduction online.
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